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ABSTRACT
Neuroblastoma (NB) is the most common pediatric extracranial solid tumor. It arises during
development of the sympathetic nervous system. Netrin-4 (NTN4), a laminin-related protein, has
been proposed as a key factor to target NB metastasis, although there is controversy about its
function. Here, we show that NTN4 is broadly expressed in tumor, stroma and blood vessels of NB
patient samples. Furthermore, NTN4 was shown to act as a cell adhesion molecule required for the
migration induced by Neogenin-1 (NEO1) in SK-N-SH neuroblastoma cells. Therefore, we propose
that NTN4, by forming a ternary complex with Laminin γ1 (LMγ1) and NEO1, acts as an essential
extracellular matrix component, which induces the migration of SK-N-SH cells.
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Pediatric solid tumors represent about 30% of pediatric
cancers. Neuroblastoma (NB) is an extracranial solid
tumor that emerges from neural crest cells during devel-
opment and it is a highly metastatic cancer [1]. The lami-
nin-related secreted Netrins (Netrin 1–4) act as versatile
extracellular cues regulating axon guidance [2], angiogen-
esis, survival and cell proliferation during embryogenesis as
well as in cancer [3].We have recently shown that Netrin-4
(NTN4) promotes NB progression andmetastasis acting as
a chemotaxis stimulus for the Neogenin-1 (NEO1) recep-
tor [4]. NEO1, a member of the immunoglobulin super-
family of transmembrane protein receptors, and its
homologue, the Deleted in Colorectal Cancer receptor
(DCC), have been related to tumor progression, prolifera-
tion, angiogenesis, apoptosis, and migration in several tis-
sues [5–9]. However, contrasting with our results, NTN4
was recently proposed to signal independently of classical
Netrin NEO1/DCC receptors [10]. In line with the former
observation, NTN4 protein structure was determined and
proposed as a cell adhesion molecule, acting as an extra-
cellular matrix protein that forms a high-affinity complex
with laminin γ1 (LMγ1) [11]. Added to this information,
data by Staquicini et al. [12] suggested the formation of a
complex between NTN4 and LMγ1 that activates a signal-
ing pathway mediated by a6β1 integrin, participating
thereby in the migration of neural stem cells. Hence, in
this study, we aimed to examine the short range-effects of
NTN4 on NB cell migration. To this end, by using the SK-
N-SH cell line, we demonstrate a role for NTN4 acting as a
cell adhesion molecule in the extracellular matrix, con-
tained within a NTN4/NEO1/LMγ1 ternary complex.
Furthermore, our results show that NTN4 is strongly
expressed in NB patient samples, in particular in endothe-
lial cells. NTN4 might act both as a cell adhesion and
chemotactic stimulus, highlighting the important contribu-
tion of the NTN4/NEO1 signaling axis in NB migration
and metastasis; a result that might reconcile the apparent
controversy in the field and thus provide a newmechanism
underlying NB metastasis.
Results
To investigate the role of NTN4 in NB, we first char-
acterized the expression of the ligand in a cohort of 23
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NB patient samples. The samples were stratified based
on the International Neuroblastoma Risk Group
Staging System (INRGSS) which contemplates a pre-
treatment risk classification system, considering tumor
spread and surgical risk factors known as Image
Defined Risk Factors (IDRFs) at the moment of diag-
nosis of the disease. Localized tumors are staged L1 or
L2 based on the absence or presence of one or more of
20 IDRFs, respectively. Metastatic tumors are defined
as stage M and MS, the latter refers to metastases
confined to the skin, liver, and/or bone marrow in
children younger than 18 months of age [13]. In
order to correlate patient’s disease staging with our
NTN4 immunohistochemistry analysis, we organized
the results in relation to PCNA expression levels, age,
tumor stage, patient status, gender and primary tumor
sites. Particularly, we evaluated NTN4 presence in
tumor cells, stroma and blood vessels (Table 1).
Despite the wide spectrum of NB presentation and
clinical course [13–15] our data show that NTN4 is
strongly expressed in NB. Notably, the number of
male patient’s biopsies expressing NTN4 is twice the
number of female biopsies expressing it. Another intri-
guing result is that no NTN4 expression was found in
tumor cells or stroma of patient’s whose primary tumor
location was ascribed at the thoracic level. Despite these
observations, statistically there is no association
between the percentage of NTN4 and these clinical
features. Interestingly, NTN4 was intensely expressed
in the endothelium (Figure 1) throughout all the sam-
ples analyzed, independent of the tumor stage
(Figure S1). Corroborating our results, NTN4 indeed
has been described as an endothelium lamina basal
component in another context such as hemangiogen-
esis [16]. In a representative NB section, defined by
classification criteria as characteristic of a disseminated
tumor stage, primitive neuroblasts, identified as small,
round and blue cells with almost no cytoplasm,
grouped in small nests (Figure 1(a), asterisk) and are
easily distinguished from the ganglionar apparent cells.
The latter are revealed by hematoxylin and eosin stain-
ing as cells with abundant eosinophilic cytoplasm,
nucleus with vesicular chromatin and a prominent
nucleolus (Figure 1(a), arrowhead). NTN4 expression
in this tumor is localized mostly in blood vessels and
stroma (Figure 1(b, f)). PCNA expression in this sam-
ple is very high (PCNA > 40%), corroborating the
aggressive stage of this NB sample (Figure 1(c)).
Strong NTN4 expression can be found in the endothe-
lium, seeming to delineate the CD31 positive blood
vessels (Figure 1(d), arrows; inset, Figure S2). Within
the tumor cells, NTN4 expression is located in the
cytoplasm surrounding the nucleus (Figure 1(e), arrow-
head). NTN4 expression is also highly upregulated
within the extracellular matrix in regions of high cel-
lular density (Figure 1(f), asterisk).
Next, we aimed to examine the effects of NTN4 on
NEO1 driven cell adhesion and migration. To this
end, we evaluated first whether NTN4 behaves as an
adhesion molecule in a NB cell line. We performed
an adhesion assay with SK-N-SH cells, at different
times, using rhNTN4 (2 μg/ml, according to [11]),
or mouse Laminin-1 (10 μg/ml) (mLM-111), as a
positive control. As indicated in Figure 2(a), NTN4
acts as an adhesion molecule, as corroborated by
quantification (Figure 2(b)), revealing significant dif-
ferences at 30 min of adhesion, when compared with
the PBS control condition. Importantly, NTN4 acted
as an adhesion molecule, inducing the adhesion of
SK-N-SH cells to a similar extent as compared with
Table 1. Characterization of NTN4 expression in patients with NB. Percentage of NTN4 positive samples distinguishing for tumor
cells, stroma and/or blood vessel expression, according to specific clinical characteristics of the patients. We do not found association
between percentage of NTN4 and clinical features. Asterisk for p value from fisher’s exact test.
Clinical Feature
% of NTN4 positive tumor cells
Samples
% of NTN4 positive
Stroma Samples
% of NTN4 positive Blood
vessel Samples χ2 df p
Gender Male 78 78 100 1.23 2 0.54
Female 36 50 100
Age > 18M 63 45 100 1.34 2 0.51
< 18M 42 75 100
Tumor Stage Disseminated
(M, MS)




PCNA > 40% 45 45 100 0.53 2 0.77
< 40% 58 75 100
Primary Tumor
Sites
Cervical 100 100 100 0.54 8 0.71/0.84*
Thoracic 0 0 100
Abdominal 33 83 100
Retroperitoneal 60 60 100
Adrenal 60 40 100
Patient Status Dead 60 40 100 0.43 2 0.81/0.81*
Recovered 53 67 100
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mLM-111. In order to determine whether NEO1 is
also important to adhesion in SK-N-SH cells, we
performed a spreading assay using control cells
(shSCR) or NEO1 knockdown cells (shNEO1),
(Figure 2(c)), demonstrating that shNEO1 cells
spread less than control cells on a Fibronectin sub-
strate, indicating that NEO1 indeed contributes to cell
adhesion and spreading (Figure 2(d)). Furthermore,
to evaluate the requirement of NEO1 in the context
of a cell adhesion induced-migration, provided parti-
cularly by NTN4, a transwell assay was tested in
shSCR or shNEO1 cells. rhNTN4 and/or mLM-111
were placed at the transwell and the assay was per-
formed according to [17] using low serum as a che-
motactic stimulus in the bottom part of the chamber.
As shown in Figure 3(a) shNEO1 cells migrated less
than the shSCR cells in both conditions, mLM-111
and rhNTN4, even when using a combination of both
molecules. Quantifications revealed no significant dif-
ferences between shSCR and shNEO1 cells at basal
migration (i.e., using PBS as stimulus, Figure 3(b)),
probably due to dispersion of the data. However,
when using either mLM-111 or rhNTN4, migration
was 2-fold increase in shSCR, with respect to shNEO1
cells, further supporting that NTN4 promotes cell
adhesion and migration to a similar extent as for
mLM-111 . According to the observations of Reuten
et al. [11], cell migration is likely modulated by
NEO1, since silencing of the receptor prevented cell
migration. Finally, combined use of mLM-111 and
NTN4 led to a non–significant increase in cell migra-
tion of shSCR cells, when compared to each separate
ligand. In our previous work [4], NTN4 was postu-
lated as a chemotactic molecule that promotes migra-
tion of NB cells. Now, based on these observations,
we reasoned that NTN4 could also act as an adhesion
molecule, in conjunction with Laminin LMγ1.
According to Reuten et al. [11], NTN4 does not
interact directly with any of the putative Netrin´s
family canonical receptors, such as NEO1. However,
others and we have shown that NTN4 immunopreci-
pitates with NEO1 [4,7]. This suggests that the inter-
action between NEO1 and NTN4 is rather indirect,
most probably forming part of a complex with LMγ1.
Indeed, studies by Staquinini et al. [12] and Reuten
et al. [11] demonstrated an interaction between
NTN4 and LMγ1. To assess whether NEO1 also
combines with LMγ1 and thus could explain a func-
tional protein complex linking NTN4 with NEO1, we
performed co-immunoprecipitation assays. Reciprocal
co-immunoprecipitation experiments demonstrated
that such association is effective on SK-N-SH cells
(Figure 3(c, d)). These results show that NEO1
associates with the LMγ1 chain and presumably,
this interaction accounts for the reduction of cell
migration observed in NEO1 knockdown cells.
Figure 1. Immunohistochemistry of NTN4 expression within NB. Representative light microscopy images of a neuroblastoma sample from
a female patient (age > 18M); tumor with retroperotineal location and in disseminated stage. (a) Hematoxylin and eosin staining reveals
presence of ganglionar-differentiated cells (yellow arrowhead) and primitive neuroblasts (yellow asterisk). (b) Immunohistochemistry of
NTN4 with its corresponding negative control (inset). (c) PCNA staining. (d) NTN4 is expressed preferentially in the endothelium (yellow
arrows), as confirmed by CD31 staining (inset). (e) Detail of ganglionar-differentiated cells with strong NTN4 cytoplasmic expression in a
characteristic punctuated pattern (yellow arrowhead). (f) Close up image of (b) as indicated, highlighting NTN4 expression within the
stroma (yellow asterisk). A, B, C; Scale bar = 40 μm. D, E, F; Scale bar = 10 μm; inset = 10 μm.
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Taken together, our results confirm that NTN4 acts
as a cell adhesion molecule, promoting serum-induced
cell migration in the NB cell line SK-N-SH through a
ternary complex formed by NTN4/NEO1/LMγ1.
Discussion
The spectrum of NB and prognosis is wide, ranging from
an aggressive course with poor survival, differentiation of
NB into more differentiated ganglio-neurona, or even
spontaneous tumor regression. Due to the high metastatic
rate of NB targeted therapies, aimed at modulating those
critical processes that are critical for tumor growth and
metastasis, are required.
NTN4 is a protein involved in many physiological
processes, such as angiogenesis [7], neovascularization
[18], axon branching [19] among others. NTN4 has
been implicated as a prognosis marker of certain
Figure 2. NTN4 as a cell adhesion molecule and NEO1 contributes to cell spreading of SK-N-SH cells. (a) Representative images are
shown for cell adhesion assays, using 2 μg/ml rhNTN4 or 10 μg/ml mLM-111 (positive control) at the indicated time points (N = 3).
Scale bar = 100 μm. (b) Quantification of cell adhesion assays shown in A. N = 3, n = 15 fields per condition at time points indicated
in A. Bonferroni posttest, *p < 0,05 PBS versus mLM-111 or rhNTN4 in 30 min of adhesion, α p < 0,05 PBS versus rhNTN4 in 60 min of
adhesion. (c) Representative images of spreading assay performed with shSCR and shNEO1 SK-N-SH cells which spreaded into
Fibronectin (2µg/ml) for 1h. Falloidin staining was used to evaluate cell spread. Yellow arrows indicate the different phenotype in
spreading of the shNEO1 cells. Bar = 100 µm. (d) Quantification of the spreading assay, where results are expressed as percentage of
spreaded cells. n = 23, ** p < 0.01 shSCR versus shNEO1 spreaded cells (black asterisk) or shNEO1 spreaded cells versus no spreaded
cells (white asterisk).
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malignancies such as gastric [20] and breast cancer
[21]. In both cancers, it has been shown that NTN4
has a role in the migration and/or metastasis of tumor
cells, without specifying the mechanism associated with
these functions. Based on our results, we can state that
NTN4 is expressed in all NB samples, although with
different cellular distribution. By analyzing the patient
cohort samples, NTN4 reveals labeling in the endothe-
lium of all sections (Figure S2), probably delineating
the basal lamina [22]. In agreement with our observa-
tions, NTN4 has been described as integral component
of the basal lamina of the endothelium and is highly
enriched in the proximal basement membrane of
tubules [23]. Indeed, our studies revealed positive
LMγ1 staining in blood vessels located within the
tumor niche (Figure S2). Moreover, our analysis sug-
gests that NEO1 can also be expressed in blood vessels
(Figure S2). Probably, tumor cells are attracted to
endothelial capillaries as they disseminate and, NTN4,
produced as a chemotactic molecule in this permissive
substrate, might facilitate their migration. NTN4 is also
observed in the stroma, especially in samples that have
Figure 3. NTN 4 induces cell migration in neuroblastoma cell line, SK-N-SH, through NEO1/Lamimin γ1 interaction (a) Representative
images of transwell assays using rhNTN4 and mLM-111 as adhesion molecules in SK-N-SH cells shSCR and shNEO1. Briefly, transwell
assays were performed in chambers with an 8μm-pore membrane. Chambers were pre-treated with PBS, 10 μg/ml mLM-111 and/or
2 μg/ml rhNTN4 and placed on the underside of the membrane for 12h before performing the assay. As a chemotactic stimulus
DMEM medium supplemented with 5% FBS was used. Cell migration was allowed for 2 h and analysis was performed as described in
the material and methods. Data were normalized with respect to shSCR cells (PBS condition). Scale bar 100 μm. (b) Quantification of
transwell assays obtained in C. Migrated cells were counted using inverted microscopy at 100x magnification. Five fields per
condition were counted and data represent the average from three independent experiments. Data was normalized to shSCR cells
(PBS condition). Mann Whitney t-test *p < 0,05 shSCR PBS versus shSCR mLM-111, rhNTN4 or both, α p < 0,05 shSCR versus shNEO1
in the same cell adhesion stimulus. (c), (d) Representative western blots of protein co-immunoprecipitation assays used to evaluate
interaction between NEO1 and LMγ1 in SK-N-SH cells. Cells were lysed and incubated using specific antibodies against either LMγ1
(c) or NEO1 (d) followed by western blot against NEO1 and LMγ1.
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the histological appearance of neuropil. In tumor cells,
NTN4 labels in a distinctive punctuated pattern, sug-
gestive of strong expression in secretory organelles,
observations that need to be further defined. Thus,
NTN4 could be acting both in autocrine and paracrine
fashion in the tumor niche.
Interestingly, the expression of NTN4 in primary
tumors located in the thoracic region was null.
Supplementary studies are required aiming to increase the
number of samples with this location of NB in order to be
able to assure that there is a relationship between the loca-
tion of the primary tumor and the absence of NTN4.
Historically, NTN4 has been postulated as a chemo-
tactic molecule [4,19]. Nevertheless, a recent study
demonstrated that this molecule could be a putative com-
ponent of the extracellular matrix, through its high affi-
nity with LMγ1, evidencing that secreted NTN4 could
function in an autocrine fashion [11]. Our group has
shown that NTN4 promotes the migration, survival, and
metastasis of NB cells through NEO1 by acting as a
chemotactic molecule on NB cells [4]. Here, we show
that NTN4 also could act as a cell adhesion molecule
inducing cell migration. In addition, we provide evidence
that NEO1 contributes to cell spreading, indicating its
function in the initiation of cell migration. Transwell
migration assays adding rhNTN4 in the underside of the
chamber generated a positive cell migration of control NB
cells (shSCR), similar to the results obtained with mLM-
111 . Interestingly, when using a combination of mLM-
111 and rhNTN4, cell migration was not significantly
different to that observed using separate ligands, although
there is a tendency. Knockdown of NEO1 reduces the cell
migration of SK-N-SH cells in all conditions, except in the
non-stimulated control (PBS), revealing that NEO1 is also
indispensable for adhesion-induced migration. This phe-
nomenon could be explained on the basis that NEO1
associates with LMγ1 in this context. It is known that
LMγ1 binds to integrin α6β1 [24]. Hence, most probably
the interaction of NEO1 with NTN4 shown in [4], could
be explained due to the formation of a ternary complex,
including NTN4, LMγ1 and NEO1. At this point, we do
not rule out that integrins also form part of the complex, a
matter that deserves further investigation. Importantly,
the combined action of all these molecules may be a key
signaling event driving NB migration and dispersion.
Materials and methods
Patient samples
Ethics committees from University of Chile and
CONICYT approved this study. General written con-
sent was obtained from all the patients enrolled by
HNPG, at diagnosis. All human tumor samples used
in this study were diagnosed, and morphologically typi-
fied, through histological analysis at the
Anatomopathology Center of this institution.
Immunohistochemistry and histological analysis
Paraffin-embedded samples of NB were deparaffinated
and rehydrated as in [25]. Immunohistochemical assays
were proceeded incubating the tissues with primary
antibodies anti-human NTN4 (AF1254, goat, R&D
Systems), anti LMγ1 (MAB1920, Millipore), anti
CD31 (P8590, mouse, Sigma), anti NEO1 (H-175,
Santa Cruz) and anti-human PCNA (13–3900, mouse,
Invitrogen), overnight at 4°C and subsequently with the
secondary biotinylated anti-goat Igg (R&D Systems) for
NTN4 analysis, and biotinylated anti-rabbit/mouse IgG
(Vector Labs) for PCNA analysis for one hour at room
temperature (25°C). The samples were later revealed
with 39-diaminobenzidine (DAB, Roche). Samples
were stained with Hematoxilin (Vector Laboratories,
Burlingame CA) and Eosin Y (Sigma Aldrich, St
Louis, MO). Immunofluorescence samples were incu-
bated an extra hour with a Donkey anti goat Alexa
Fluor 555 (Invitrogen). Dapi was used for nuclei stain-
ing. Slices were mounted with fluorescence mounting
medium (Dako). PCNA percentage was calculated by
counting by two independent observers the number of
cells marked in quadrants and multiplying by the total
number of quadrants present in each sample. 40% was
the median obtained for the total of 23 samples. χ
square and Fisher’s exact test (n < 5 samples) were as
statistical tests.
Cell culture
The NB cell line SK-N-SH, was cultured in high glucose
Dulbecco’s Modified Eagle Medium (DMEM,
Invitrogen) with 5% fetal bovine serum (FBS, Gibco)
and supplemented with antibiotics (Penicillin-
Streptomycin, 10,000 U/mL). To knock-down NEO1
(shNEO1), SK-N-SH were transduced according to [4]
assessing knockdown efficiency via Western Blot. Stable
shNEO1 and shSCR (control) SK-N-SH cells were pre-
viously established, using puromycin as a selection
marker, as indicated in [4].
Cell adhesion assay
48-well plates were incubated overnight at 4ºC with
PBS, mouse Laminin-1 (mLM-111) (Invitrogen,
extracted from Engelbreth-Holm-Swarm sarcoma)
(10μg/ml) or rhNTN4 (2μg/ml). Next, SK-N-SH cells
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(70,000) were placed into the wells and allowed to
adhere at different times (0, 5, 10, 15, 30, 45 and
60 minutes). At indicated time points, cells were fixed
and stained using 0.1% crystal violet in 20% methanol
saline (0.15 M NaCl). Photographs were taken to eval-
uate adhesion and results are presented as the number
of adherent cells per condition.
Spreading assay
ShSCR and shNEO1 SK-N-SH cells were seeded on
coverslips pre-covered with Fibronectin (2 μg/ml) for
1 h. Then, the cells were fixed with PFA 4% w/v
followed by staining with phalloidin-546
(Thermofisher) and DAPI. Cells were observed and
documented by confocal microscopy (Zeiss 710). A
total of 23 spreading cells was quantified per condition.
Transwell migration assays
Transwell assays were completed using a chamber
within an 8μm-pore polycarbonate membrane
(Corning). As a cell adhesion stimulus, 10 μg/ml
mLM-111 (Invitrogen) and/or 2 μg/ml rhNTN4
(R&D systems) were placed on the underside of the
transwell membrane 12h before performing the assay,
dissolved in Phosphate buffered saline (PBS), which
was used as a control. As a chemotactic stimulus
DMEM 5% Fetal Bovine Serum (FBS) was used at
the bottom of the chamber. Briefly, 50,000 shNEO1
or shSCR SK-N-SH cells were placed in the upper
chamber. The cells were incubated for 2h, fixed and
stained with crystal violet solution. All results were
normalized with respect to the PBS condition of the
shSCR cells.
Protein co-immunoprecipitation
SK-N-SH cells were used to prepare cell extracts with a
buffer containing 20 mM Tris, pH 7.4, 150 mM NaCl,
1% NP-40, and protease inhibitors by 5 min incubation
on ice. Samples were centrifuged at 13,000 × g by 1 min
at 4°C, and supernatants (1000 μg total protein) were
immunoprecipitated with Dynabeads protein A
(Thermofisher) bead-immobilized antibodies for 1h.
NEO1 was immunoprecipitated with 2 μg of a rabbit
polyclonal antibody (H-175, Santa Cruz) and LMγ1 was
immunoprecipitated with 2 μg of mouse monoclonal
antibody (MAB1920, Millipore). Immunoprecipitated
samples were solubilized in loading buffer with ß-
mercaptoethanol, and analyzed by Western blot as
indicated in (Figure 3).
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